XML 47 R31.htm IDEA: XBRL DOCUMENT v3.23.1
REVENUES (Tables)
 3 Months Ended
Mar. 31, 2023
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenues
The following tables present the disaggregation of the Company’s revenues by customer location, including a reconciliation of the disaggregated revenues with the reportable segments (Note 14 “Segment Information”) for the periods indicated:
Three Months Ended March 31, 2023
Reportable Segments
North AmericaEuropeRussiaConsolidated Revenues
Customer Locations
Americas$683,553 $25,954 $295 $709,802 
EMEA25,372 438,565 — 463,937 
APAC726 26,084 — 26,810 
CEE306 2,544 7,542 10,392 
        Revenues$709,957 $493,147 $7,837 $1,210,941 

Three Months Ended March 31, 2022
Reportable Segments
North AmericaEuropeRussiaConsolidated Revenues
Customer Locations
Americas$659,776 $25,960 $1,057 $686,793 
EMEA25,098 396,753 99 421,950 
APAC783 28,799 — 29,582 
CEE2,054 458 30,777 33,289 
        Revenues$687,711 $451,970 $31,933 $1,171,614 
The following tables present the disaggregation of the Company’s revenues by industry vertical, including a reconciliation of the disaggregated revenues with the reportable segments (Note 14 “Segment Information”) for the periods indicated:
Three Months Ended March 31, 2023
Reportable Segments
North AmericaEuropeRussiaConsolidated Revenues
Industry Verticals
Travel & Consumer$123,659 $153,055 $1,646 $278,360 
Financial Services143,850 123,608 3,207 270,665 
Business Information & Media116,158 86,108 114 202,380 
Software & Hi-Tech149,798 38,682 711 189,191 
Life Sciences & Healthcare96,597 14,526 135 111,258 
Emerging Verticals79,895 77,168 2,024 159,087 
        Revenues$709,957 $493,147 $7,837 $1,210,941 

Three Months Ended March 31, 2022
Reportable Segments
North AmericaEuropeRussiaConsolidated Revenues
Industry Verticals
Travel & Consumer$122,247 $136,788 $6,284 $265,319 
Financial Services120,335 117,330 22,398 260,063 
Business Information & Media110,946 82,901 456 194,303 
Software & Hi-Tech156,282 32,454 747 189,483 
Life Sciences & Healthcare111,371 12,282 150 123,803 
Emerging Verticals66,530 70,215 1,898 138,643 
        Revenues$687,711 $451,970 $31,933 $1,171,614 
The following tables present the disaggregation of the Company’s revenues by contract type including a reconciliation of the disaggregated revenues with the Company’s reportable segments (Note 14 “Segment Information”) for the periods indicated:
Three Months Ended March 31, 2023
Reportable Segments
North AmericaEuropeRussiaConsolidated Revenues
Contract Types
Time-and-material$644,628 $425,598 $4,753 $1,074,979 
Fixed-price61,231 66,203 3,071 130,505 
Licensing and other revenues4,098 1,346 13 5,457 
        Revenues$709,957 $493,147 $7,837 $1,210,941 
Three Months Ended March 31, 2022
Reportable Segments
North AmericaEuropeRussiaConsolidated Revenues
Contract Types
Time-and-material$626,807 $377,655 $18,691 $1,023,153 
Fixed-price56,765 73,608 13,190 143,563 
Licensing and other revenues4,139 707 52 4,898 
        Revenues$687,711 $451,970 $31,933 $1,171,614 

Timing of Revenue Recognition
The following tables present the timing of revenue recognition reconciled with the Company’s reportable segments (Note 14 “Segment Information”) for the periods indicated:
Three Months Ended March 31, 2023
Reportable Segments
North AmericaEuropeRussiaConsolidated Revenues
Timing of Revenue Recognition
Transferred over time$707,034 $492,397 $7,824 $1,207,255 
Transferred at a point of time2,923 750 13 3,686 
        Revenues$709,957 $493,147 $7,837 $1,210,941 

Three Months Ended March 31, 2022
Reportable Segments
North AmericaEuropeRussiaConsolidated Revenues
Timing of Revenue Recognition
Transferred over time$685,109 $451,848 $31,891 $1,168,848 
Transferred at a point of time2,602 122 42 2,766 
        Revenues$687,711 $451,970 $31,933 $1,171,614 
Schedule of Revenue Expected to be Recognized in Future Related to Remaining Performance Obligations The following table includes the estimated revenues expected to be recognized in the future related to performance obligations that are partially or fully unsatisfied as of March 31, 2023. The Company applies a practical expedient and does not disclose the value of unsatisfied performance obligations for contracts (i) that have an original expected duration of one year or less and (ii) for which it recognizes revenues at the amount to which it has the right to invoice for services provided.
Less than 1 year1 Year2 Years3 YearsTotal
Contract Type
Fixed-price$12,353 $3,124 $2,564 $— $18,041 
Schedule of Contract Balances
The following table provides information on the classification of contract assets and liabilities in the condensed consolidated balance sheets:
 As of
March 31,
2023		As of
December 31,
2022
Contract assets included in Trade receivables and contract assets, net$22,524 $11,490 
Contract liabilities included in Accrued expenses and other current liabilities$35,598 $36,036 
Contract liabilities included in Other noncurrent liabilities$319 $42